Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03472469 · ClinicalTrials.gov registry record · Phase 4
MAST Trial: Multi-modal Analgesic Strategies in Trauma
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,561
- Enrollment target
NCT03472469: Completed Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
NCT03472469 is a Phase 4 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 1,561 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (201% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03472469, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,561 participants
- Enrollment target
Study Summary
This is a comparative effectiveness study of current pain management strategies in acutely injured trauma patients. Two different multi-modal, opioid minimizing analgesic strategies will be compared \[original multimodal pain regimen (MMPR) compared to multi-modal analgesic strategies for trauma (MAST) MMPR\].
Primary Outcome
Opioid use per day is calculated by tallying the dose equivalency of all opioids received and dividing by the number of days hospitalized. Morphine milligram equivalents (MME) per day are reported.
Interventions
- DRUG Ketorolac
- DRUG Naproxen
- DRUG Celebrex
- DRUG Acetaminophen IV/PO
- DRUG Acetaminophen PO
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,561 participants |
| Start Date | 2018-04-02 |
| Est. Completion | 2019-07-03 |
| Phase | Phase 4 |
What the finished NCT03472469 record still lists
NCT03472469 is an interventional study that assigns participants to a tested intervention. Its 1,561 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (201% higher).
The record links to 0 conditions, and to 5 interventions - of which Ketorolac is the first listed.
NCT03472469 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03472469 about?
NCT03472469 is a clinical study titled "MAST Trial: Multi-modal Analgesic Strategies in Trauma". This is a comparative effectiveness study of current pain management strategies in acutely injured trauma patients. Two different multi-modal, opioid minimizing analgesic strategies will be compared \[original multimodal pain regimen (MMPR) compared to multi-modal analgesic strategies for trauma (MA...
What is the current status of trial NCT03472469?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,561 participants. The study started on 2018-04-02. Estimated completion is 2019-07-03.
What interventions are being tested in trial NCT03472469?
The interventions under investigation include: Ketorolac (DRUG), Naproxen (DRUG), Celebrex (DRUG), Acetaminophen IV/PO (DRUG), Acetaminophen PO (DRUG).
Who is sponsoring clinical trial NCT03472469?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03472469's enrollment target sits among peer trials
1,561 50th of 2000 higher than 1,951 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06881069 · 1,560 participants · NA
Reach Through Equitable Implementation in Utah
- NCT06034080 · 1,566 participants · NA
Interventions to De-implement Unnecessary Antibiotic Prescribing for Children With Ear Infections
- NCT06445946 · 1,572 participants · Phase 4
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
- NCT02650622 · 1,550 participants
Genetic and Metabolic Disease in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI